Effectiveness of Pharmacogenetic testing in improving pharmacologic treatment for CAF Veterans

Advances in the field of pharmacogenetics have brought much attention to the potential benefit of personalized medicine in the field of psychiatry. We will assess the value of a simple pharmacogenetic test for treatment-seeking CAF veterans. If the results from prior depression studies hold in our PTSD population, this approach holds potential to save time and money and accelerate the path to recovery by matching treatment to the profile of each patient, and therefore improving treatment outcomes (Hall-Flavin et al., 2013).

Faculty Supervisor:

Don Richardson;Anthony Nazarov

Student:

Partner:

Calian Ltd

Discipline:

Life Sciences

Sector:

Professional, scientific and technical services

University:

The University of Western Ontario

Program:

Accelerate

Related projects

Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.

View all
Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects

Mitacs Partners

The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.

Government
Academic
Industry
Innovation
International

International

Load More

International

Load More

Join a thriving innovation ecosystem.

Subscribe to our newsletter now!

Subscribe

Mitacs — Return on Innovation

Mitacs is funded by the Government of Canada, the Government of Alberta, the Government of British Columbia, Research Manitoba, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, Innovation PEI, the Government of Quebec, the Government of Saskatchewan, and the Government of Yukon.